PubMed Health⌕ Search

PubMed · 9763794

Exercise, immune function and HIV infection.

Abstract

The implications of HIV infection for exercise and sport are reviewed. HIV infection leads to impairment in a number of key elements of immune function, most obviously a progressive decline in the numbers of CD4+ T helper/inducer lymphocytes. Nevertheless, patients with early through moderately advanced HIV-1 infection can engage in moderate sport and exercise without risk to themselves or other participants; the resulting gains of aerobic power and muscle strength are similar to those observed in healthy individuals of comparable initial fitness. In fully developed AIDS, the ability to exercise may be compromised by deteriorations in cardiorespiratory and neuromuscular function. Given the impairment of resting immune function, the potential immunosuppression from very intensive bouts of competitive exercise must be avoided. Review of all published papers to date provides a relatively limited data base. During a bout of moderate physical activity, HIV seropositive individuals apparently have an impaired ability to mobilize neutrophils, NK and LAK cells into the circulation. Nevertheless, programmes of moderate training can be sustained without any large change in CD4+ count or CD4+/CD8+ ratio. In some studies, training has also attenuated psychological stress, possibly for this reason checking the anticipated fall in CD4+ count. However, further large-scale randomized and long-term studies of HIV are needed, comparing the therapeutic value of exercise alone with that of psychotherapy or a combined programme of exercise and psychotherapy.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

R J Shephard. 1998. Exercise, immune function and HIV infection.. https://pubmed.ncbi.nlm.nih.gov/9763794/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Ex vivo phenotype and frequency of influenza virus-specific CD4 memory T cells.

Recent advances in class II tetramer staining technology have allowed reliable direct ex vivo visualization of antigen-specific CD4 T cells. In order to define the frequency and phenotype of a prototype response to a nonpersistent pathogen, we have used such techniques to analyze influenza virus-specific memory CD4 T cells directly from blood. These responses are stably detectable ex vivo at low frequencies (range, 0.00012 to 0.0061% of CD4 T cells) and display a distinct "central memory" CD62L(+) phenotype.

CD4-Positive T-Lymphocytes↗

Amino-terminal fragment of urokinase-type plasminogen activator inhibits HIV-1 replication.

CD8+ T lymphocytes have been shown to produce unidentified soluble factors active in suppressing HIV-1 replication. In this study, we purified an HIV-1 suppressing activity from the culture supernatant of an immortalized CD8+ T cell clone, derived from an HIV-1 infected long-term nonprogressor, and identified this activity as the amino-terminal fragment (ATF) of urokinase-type plasminogen activator (uPA). ATF is catalytically inactive, but suppresses the release of viral particles from the HIV-1 infected cell lines via binding to its receptor CD87. In contrast, cell proliferation and the secretion of an HIV-1 LTR driven reporter gene product were not affected by ATF. These findings suggest that ATF may inhibit the assembly and budding of HIV-1, which provides a novel therapeutic strategy for AIDS.

CD4-Positive T-Lymphocytes↗

Tetramer-guided epitope mapping: rapid identification and characterization of immunodominant CD4+ T cell epitopes from complex antigens.

T cell responses to Ags involve recognition of selected peptide epitopes contained within the antigenic protein. In this report, we describe a new approach for direct identification of CD4+ T cell epitopes of complex Ags that uses human class II tetramers to identify reactive cells. With a panel of 60 overlapping peptides covering the entire sequence of the VP16 protein, a major Ag for HSV-2, we generated a panel of class II MHC tetramers loaded with peptide pools that were used to stain peripheral lymphocytes of an HSV-2 infected individual. With this approach, we identified four new DRA1*0101/DRB1*0401- and two DRA1*0101/DRB1*0404-restricted, VP16-specific epitopes. By using tetramers to sort individual cells, we easily obtained a large number of clones specific to these epitopes. Although DRA1*0101/DRB1*0401 and DRA1*0101/DRB1*0404 are structurally very similar, nonoverlapping VP16 epitopes were identified, illustrating high selectivity of individual allele polymorphisms within common MHC variants. This rapid approach to detecting CD4+ T cell epitopes from complex Ags can be applied to any known Ag that gives a T cell response.

CD4-Positive T-Lymphocytes↗